In a national trial of 570 adults, suicidal ideation declined within 1 week of starting Opioid use disorder meds. Both buprenorphine-naloxone and extended-release naltrexone helped, but buprenorphine showed stronger early effects.
Kroger Agrees to Pay $1.2 Billion to Settle Opioid Claims